When Geneticists and Clinicians Mate, Outcomes Database
Sequana's agreement with Memorial Sloan-Kettering Cancer Center to form a $10 million joint venture dedicated to cancer genetics is not unlike the genes it seeks to uncover-it is unique in both structure and function. The still unnamed company, willcorrelate the genotype information gathered from breast, colon, and prostrate cancer tissue samples with Sloan-Kettering's detailed data on the original diagnosis, treatment, and outcomes of these cancers.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.